EVALUATION OF ANGIOPOIETIN-2 AS AN EARLY MARKER FOR DIABETIC NEPHROPATHY INZAGAZIG UNIVERSITY HOSPITALS

BNP, Corin and Furin as Potential Biomarkers for Cardiovascular Complications in Type 2 Diabetes Mellitus Patients

Study of The Podocalyxin as An Early Marker for Diabetic Nephropathy and Its Correlation with Stages of Diabetic Nephropathy in A Sample of Egyptian Patients with T2DM

Evalution of Biomarkers in Iraq Patients with Diabetes Mellitus Type 2

Serum CXCL16 in Relation to Diabetic Nephropathy in Type 2 Diabetes Egyptian Patients

The Association between Highly Sensitive C-Reactive Protein and Interleukin-18 with Nephropathy in a Sample of Type 1 Diabetic Egyptian Patients

Evaluation of different biochemical markers and imaging modalities in type 2 diabetes mellitus patients with and without albuminuria

Evaluation of Some Biochemical Changes in Diabetic Patients

Fibroblast Growth Factor 21 as a possible metabolic marker of diabetic nephropathy in Type 2 diabetic patients

Association of TCF7L2 rs7903146 Polymorphism with Diabetic Nephropathy in Type 2 Diabetes Mellitus Egyptian Patients